Abbott Laboratories
XHAM:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
Southern Energy Corp
XTSX:SOU
|
CA |
|
P
|
Pine Cliff Energy Ltd
OTC:PIFYF
|
CA |
|
U
|
Union Pacific Corp
XMUN:UNP
|
US |
|
International Container Terminal Services Inc
OTC:ICTEY
|
PH |
|
Mincon Group PLC
F:MIO
|
IE |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 107.49 EUR with a low forecast of 83.21 EUR and a high forecast of 127.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
107.49
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 107.49 EUR with a low forecast of 83.21 EUR and a high forecast of 127.87 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
